114 related articles for article (PubMed ID: 16245277)
1. Bystin in perineural invasion of prostate cancer.
Ayala GE; Dai H; Li R; Ittmann M; Thompson TC; Rowley D; Wheeler TM
Prostate; 2006 Feb; 66(3):266-72. PubMed ID: 16245277
[TBL] [Abstract][Full Text] [Related]
2. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
3. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
[TBL] [Abstract][Full Text] [Related]
4. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach.
Dai H; Li R; Wheeler T; Ozen M; Ittmann M; Anderson M; Wang Y; Rowley D; Younes M; Ayala GE
Hum Pathol; 2007 Feb; 38(2):299-307. PubMed ID: 17097719
[TBL] [Abstract][Full Text] [Related]
5. Growth and survival mechanisms associated with perineural invasion in prostate cancer.
Ayala GE; Dai H; Ittmann M; Li R; Powell M; Frolov A; Wheeler TM; Thompson TC; Rowley D
Cancer Res; 2004 Sep; 64(17):6082-90. PubMed ID: 15342391
[TBL] [Abstract][Full Text] [Related]
6. Cancer-related axonogenesis and neurogenesis in prostate cancer.
Ayala GE; Dai H; Powell M; Li R; Ding Y; Wheeler TM; Shine D; Kadmon D; Thompson T; Miles BJ; Ittmann MM; Rowley D
Clin Cancer Res; 2008 Dec; 14(23):7593-603. PubMed ID: 19047084
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CD146 gene expression via RNA interference reduces in vitro perineural invasion on ACC-M cell.
Chen W; Zhang HL; Jiang YG; Li JH; Liu BL; Sun MY
J Oral Pathol Med; 2009 Feb; 38(2):198-205. PubMed ID: 19200179
[TBL] [Abstract][Full Text] [Related]
9. Trophinin, tastin, and bystin: a complex mediating unique attachment between trophoblastic and endometrial epithelial cells at their respective apical cell membranes.
Fukuda MN; Nozawa S
Semin Reprod Endocrinol; 1999; 17(3):229-34. PubMed ID: 10797941
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
[TBL] [Abstract][Full Text] [Related]
11. Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma.
Ayala GE; Dai H; Tahir SA; Li R; Timme T; Ittmann M; Frolov A; Wheeler TM; Rowley D; Thompson TC
Cancer Res; 2006 May; 66(10):5159-64. PubMed ID: 16707439
[TBL] [Abstract][Full Text] [Related]
12. Bystin in human cancer cells: intracellular localization and function in ribosome biogenesis.
Miyoshi M; Okajima T; Matsuda T; Fukuda MN; Nadano D
Biochem J; 2007 Jun; 404(3):373-81. PubMed ID: 17381424
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
14. A role for class 3 semaphorins in prostate cancer.
Blanc V; Nariculam J; Munson P; Freeman A; Klocker H; Masters J; Williamson M
Prostate; 2011 May; 71(6):649-58. PubMed ID: 20949546
[TBL] [Abstract][Full Text] [Related]
15. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
[TBL] [Abstract][Full Text] [Related]
16. Biological significance of perineural invasion (PNI) in prostate cancer.
Fromont G; Godet J; Pires C; Yacoub M; Dore B; Irani J
Prostate; 2012 Apr; 72(5):542-8. PubMed ID: 21748758
[TBL] [Abstract][Full Text] [Related]
17. The significance of LMO2 expression in the progression of prostate cancer.
Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
[TBL] [Abstract][Full Text] [Related]
18. CCR2 expression correlates with prostate cancer progression.
Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
[TBL] [Abstract][Full Text] [Related]
19. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
Davies G; Ablin RJ; Mason MD; Jiang WG
J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
[TBL] [Abstract][Full Text] [Related]
20. TGFBR3 loss and consequences in prostate cancer.
Sharifi N; Hurt EM; Kawasaki BT; Farrar WL
Prostate; 2007 Feb; 67(3):301-11. PubMed ID: 17192875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]